ConductScience.org, home

Paper23313617

Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.

Westdijk J and 8 others. Vaccine, 2013. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. Papers, record 23313617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23313617

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.
PubMed
Journal
Vaccine
PubMed
Year
2013
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Westdijk JJanny
2Koedam PPatrick
3Barro MMario
4Steil BPBenjamin P
5Collin NNicolas
6Vedvick TSThomas S
7Bakker WAWilfried A M
8van der Ley PPeter
9Kersten GGideon

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
PoliovirusMajor topic
Poliovirus VaccinesMajor topic
Animals
Antibodies, Neutralizing
Antibodies, Viral
Neutralization Tests
Poliovirus Vaccine, Inactivated
Rats

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 AI070976NIAID NIH HHSUnited StatesU01AI070976PubMed and NIH
U01-AI070976NIAID NIH HHSUnited StatesU01AI070976PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122531556Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.Vaccine2012https://conductscience.org/library/papers/22531556PubMed
212899574Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant.Expert Rev Vaccines2003https://conductscience.org/library/papers/12899574PubMed
318440205Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions.Colloids Surf B Biointerfaces2008https://conductscience.org/library/papers/18440205PubMed
421684427The Vaccine Formulation Laboratory: a platform for access to adjuvants.Vaccine2011https://conductscience.org/library/papers/21684427PubMed
5164251401,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.J Infect Dis2006https://conductscience.org/library/papers/16425140PubMed
622415641Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.AAPS PharmSciTech2012https://conductscience.org/library/papers/22415641PubMed
721906648Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.Vaccine2011https://conductscience.org/library/papers/21906648PubMed
89434729Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.Virology1997https://conductscience.org/library/papers/9434729PubMed
91845806Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.J Infect Dis1991https://conductscience.org/library/papers/1845806PubMed
1010590126Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.J Virol2000https://conductscience.org/library/papers/10590126PubMed
1119729087CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.Vaccine2009https://conductscience.org/library/papers/19729087PubMed
1216505353Mucosal and systemic adjuvant activity of alphavirus replicon particles.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16505353PubMed
1320550484Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions.Pharm Dev Technol2011https://conductscience.org/library/papers/20550484PubMed
142053280Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.Virology1991https://conductscience.org/library/papers/2053280PubMed
1518704954Vaccine adjuvants: current challenges and future approaches.J Pharm Sci2009https://conductscience.org/library/papers/18704954PubMed
1622884665Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.Vaccine2013https://conductscience.org/library/papers/22884665PubMed
1720184975Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.Vaccine2010https://conductscience.org/library/papers/20184975PubMed
186262142Potency testing of killed polio vaccine in rats.Dev Biol Stand1981https://conductscience.org/library/papers/6262142PubMed
1911226454Immunoglobulin subclass responses of wild brown rats to Sarcocystis singaporensis.Int J Parasitol2001https://conductscience.org/library/papers/11226454PubMed
2021162624Combination adjuvants: the next generation of adjuvants?Expert Rev Vaccines2011https://conductscience.org/library/papers/21162624PubMed

See all 30 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
36576132Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication.Hum Vaccin Immunother2022https://conductscience.org/library/papers/36576132PubMed
35968964RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.mSphere2022https://conductscience.org/library/papers/35968964PubMed
35563292Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity.Int J Mol Sci2022https://conductscience.org/library/papers/35563292PubMed
33066050In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine.Vaccines (Basel)2020https://conductscience.org/library/papers/33066050PubMed
32411401H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets.NPJ Vaccines2020https://conductscience.org/library/papers/32411401PubMed
29601259Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV).Hum Vaccin Immunother2018https://conductscience.org/library/papers/29601259PubMed
28794452The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin.Sci Rep2017https://conductscience.org/library/papers/28794452PubMed
27470209Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.Vaccine2016https://conductscience.org/library/papers/27470209PubMed
27317570Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles.Pharm Res2016https://conductscience.org/library/papers/27317570PubMed
27066157Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies.Trials Vaccinol2015https://conductscience.org/library/papers/27066157PubMed
25483682Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.Hum Vaccin Immunother2014https://conductscience.org/library/papers/25483682PubMed
24956110Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.PLoS One2014https://conductscience.org/library/papers/24956110PubMed
24760448Development of thermostable lyophilized inactivated polio vaccine.Pharm Res2014https://conductscience.org/library/papers/24760448PubMed
24469907Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.Pharm Res2014https://conductscience.org/library/papers/24469907PubMed
24349497Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.PLoS One2013https://conductscience.org/library/papers/24349497PubMed
24333345A mucosal adjuvant for the inactivated poliovirus vaccine.Vaccine2014https://conductscience.org/library/papers/24333345PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23313617

GET https://conductscience.org/api/papers/v1/23313617/references?page=2